Clioquinol Ointment
If you find any inaccurate information, please let us know by providing your feedback here

Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Clioquinol Ointment contains NLT 90.0% and NMT 110.0% of the labeled amount of clioquinol (C9H5ClINO) in a suitable ointment base.
2 IDENTIFICATION
A.
Standard solution: Prepare as directed for the Standard solution in the Assay, except use 1.0 mL of pyridine instead of the Internal standard solution.
Acceptance criteria: The retention time of the major peak of the Sample solution, as obtained in the Assay, corresponds to that of the Standard solution.
B.
Sample solution: Place nominally 25 mg of clioquinol from Ointment in a 100-mL volumetric flask, add 75 mL of dilute hydrochloric acid (1 in 4), and heat on a steam bath to melt the Ointment, shaking vigorously to extract the clioquinol. Cool under running water, and add dilute hydrochloric acid (1 in 4) to volume. Filter through paper, and dilute 3 mL of the filtrate with dilute hydrochloric acid (1 in 4) to 100 mL. Acceptance criteria: The UV absorption spectrum of the Sample solution exhibits maxima and minima at the same wavelengths as that of a similar solution of USP Clioquinol RS, concomitantly measured.
3 ASSAY
Procedure
Internal standard solution: 2 mg/mL of pyrene in pyridine
Standard stock solution: 3 mg/mL of USP Clioquinol RS in a mixture of pyridine and n-hexane (4:1)
Standard solution: Transfer 1.0 mL of the Standard stock solution to a screw-capped glass vial fitted with a septum, add 1.0 mL of bis(trimethylsilyl)acetamide and 1.0 mL of Internal standard solution, and attach the cap. Heat in a water bath at 50° for 15 min, and then cool to ambient temperature.
Sample solution: Transfer nominally 150 mg of clioquinol from Ointment to a 125-mL separator. Add 75 mL of n-hexane, then add 15 mL of dimethylformamide, and mix for 1 min. Allow the layers to separate, and transfer the lower layer to a 50-mL volumetric flask. Repeat the extraction with separate 15- and 10-mL portions of dimethylformamide, and transfer the lower layers to the 50-mL volumetric flask. Dilute with dimethylformamide to volume. Transfer 1.0 mL of this solution to a screw-capped glass vial fitted with a septum, and evaporate at 60° under a stream of nitrogen to dryness. Add 1.0 mL of a mixture of pyridine and n-hexane (4:1) to the residue, add 1.0 mL of bis(trimethylsilyl)acetamide and 1.0 mL of Internal standard solution, and attach the cap. Heat in a water bath at 50° for 15 min, then cool to ambient temperature.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: GC
Detector: Flame ionization
Column: 1.83-m × 2-mm glass; packed with 3% liquid phase G3 on 80- to 100-mesh support S1AB
Temperatures
Column: The initial temperature is 200° for a conditioning period of NLT 16 h (not connected to the detector) and is then reduced to 165°. Injection port: 170°
Detector: 250°
Carrier gas: Helium
Flow rate: 30 mL/min for helium. Hydrogen and air are introduced into the detector at rates of 25 and 500 mL/min, respectively. Injection volume: 1 µL
System suitability
Sample: Standard solution
[Note—The relative retention times for clioquinol and pyrene are 0.6 and 1.0, respectively.]
Suitability requirements
Resolution: NLT 3 between the clioquinol and the internal standard peaks
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of clioquinol (C9H5ClINO) in the portion of Ointment taken:
Result = (RU/RS) × (CS/CU) × 100
rU = peak response ratio of clioquinol to the internal standard from the Sample solution
rS = peak response ratio of clioquinol to the internal standard from the Standard solution
CS = concentration of USP Clioquinol RS in the Standard solution (mg/mL)
CU = nominal concentrationof clioquinol in the Sample solution (mg/mL)
Acceptance criteria: 90.0%–110.0%
4 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in collapsible tubes or tight, light-resistant containers.
USP Reference Standards 〈11〉
USP Clioquinol RS

